Kezar Life Sciences (KZR) Earnings Date and Reports 2024

2 days ago · Kezar Life Sciences issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$2.78, which beat analysts' consensus estimates of -$3.03 by $0.25. With a trailing EPS of -$13.18, Kezar Life Sciences' earnings are expected to grow next year, from ($11.95) to …

CouponFollow Extension

$2.78
OFF

Kezar Life Sciences (KZR) Earnings Date And Reports 2024

1 week from now

marketbeat.com

76%
OFF

Kezar Life Sciences Earnings Dates, Reports, Calls 2014-2024 …

1 week from now

On KZR's earnings call on Invalid Date, . Kezar Life Sciences (NASDAQ: KZR) reported Q2 2024 earnings per share (EPS) of -$3.00, up 11.76% year over year. Total KZR earnings for the …

wallstreetzen.com

$148
OFF

Kezar Life Sciences Reports Third Quarter 2024 Financial Results …

1 week from now

4 days ago · Kezar Life Sciences reported Q3 2024 financial results and provided updates on its clinical trials. The company's cash position stood at $148.4 million as of September 30, 2024. …

stocktitan.net

$7.49
OFF

Kezar Life Sciences (KZR) Receives A Buy From TD Cowen

1 week from now

3 days ago · TD Cowen analyst Phil Nadeau maintained a Buy rating on Kezar Life Sciences (KZR – Research Report) yesterday.The company’s shares closed yesterday at $7.49. …

businessinsider.com

FAQs about Kezar Life Sciences (KZR) Earnings Date and Reports 2024 Coupon?

When does Kezar life sciences (KZR) announce earnings?

Kezar Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on KZR's earnings history. How much profit does Kezar Life Sciences generate each year? ...

How much did Kezar life sciences lose?

Based on Kezar Life Sciences’ latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $21.55 million. In comparison, last year the company had a GAAP net loss of $24.31 million TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. ...

What is the 12-month price forecast for Kezar life sciences (KZR)?

The 12-month stock price forecast is $20.0, which is an increase of 171.37% from the latest price. NEW YORK-- (BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Kezar Life Sciences, Inc. (Nasdaq: KZR) concerning the Company and its directors' and officers' possible v... ...

Is Kezar Life Sciences a good stock to buy?

The word on The Street in general, suggests a Hold analyst consensus rating for Kezar Life Sciences with a $20.00 average price target. Based on Kezar Life Sciences’ latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $21.55 million. ...

Who is Kezar life sciences?

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. ...

Should you buy Kezar life sciences (Kadeau)?

According to TipRanks, Nadeau has an average return of 7.1% and a 48.25% success rate on recommended stocks. The word on The Street in general, suggests a Hold analyst consensus rating for Kezar Life Sciences with a $20.00 average price target. ...